Allopurinol, gout, and cardiovascular risk - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Allopurinol's Impact on Gout and Associated Cardiovascular Risks

  • By

  • Jalina Jannink

  • Arend Mosterd

  • Aernoud T L Fiolet

  • October 29, 2025

Share

Original Source(s)

Allopurinol, gout, and cardiovascular risk

  • by Jalina Jannink, Arend Mosterd, Aernoud T L Fiolet

  • October 29, 2025

Related Content

Author Correction: Effect of a digital health behaviour change support system on cardiovascular disease risk in a randomized weight loss trial

Error in Author Name

  • September 3, 2026

Correction: The inflammatory marker SIRI acts as a statistical mediator between ApoB/ApoA1 ratio and atrial fibrillation, and combined biomarkers show higher discriminative ability for the presence of atrial fibrillation than single indicators